- Home
- MFIN vs STIM Comparison
MFIN vs STIM Comparison
Compare MFIN & STIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MFIN
- STIM
- Stock Information
- Founded
- MFIN 1995
- STIM 2003
- Country
- MFIN United States
- STIM United States
- Employees
- MFIN N/A
- STIM N/A
- Industry
- MFIN Finance: Consumer Services
- STIM Medical/Dental Instruments
- Sector
- MFIN Finance
- STIM Health Care
- Exchange
- MFIN Nasdaq
- STIM Nasdaq
- Market Cap
- MFIN 243.9M
- STIM 224.8M
- IPO Year
- MFIN 1996
- STIM 2018
- Fundamental
- Price
- MFIN $9.85
- STIM $2.69
- Analyst Decision
- MFIN Strong Buy
- STIM Strong Buy
- Analyst Count
- MFIN 1
- STIM 2
- Target Price
- MFIN $12.00
- STIM $7.00
- AVG Volume (30 Days)
- MFIN 33.9K
- STIM 1.1M
- Earning Date
- MFIN 10-30-2025
- STIM 11-11-2025
- Dividend Yield
- MFIN 4.85%
- STIM N/A
- EPS Growth
- MFIN N/A
- STIM N/A
- EPS
- MFIN 1.75
- STIM N/A
- Revenue
- MFIN $332,256,000.00
- STIM $111,106,000.00
- Revenue This Year
- MFIN N/A
- STIM $105.70
- Revenue Next Year
- MFIN $1.53
- STIM $11.77
- P/E Ratio
- MFIN $5.65
- STIM N/A
- Revenue Growth
- MFIN 16.48
- STIM 54.17
- 52 Week Low
- MFIN $7.71
- STIM $0.52
- 52 Week High
- MFIN $10.98
- STIM $5.92
- Technical
- Relative Strength Index (RSI)
- MFIN 46.86
- STIM 42.01
- Support Level
- MFIN $9.78
- STIM $2.65
- Resistance Level
- MFIN $10.15
- STIM $3.21
- Average True Range (ATR)
- MFIN 0.31
- STIM 0.19
- MACD
- MFIN 0.00
- STIM 0.03
- Stochastic Oscillator
- MFIN 60.40
- STIM 22.22
About MFIN Medallion Financial Corp.
Medallion Financial Corp is a finance company that originates and services loans in various industries. The five operating segments are, (1) recreation, (2) home improvement, (3) commercial, (4) taxi medallion, and (5) strategic partnership loans. The company generates maximum revenue from the Recreation segment.
About STIM Neuronetics Inc.
Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.